Valcreate Lifesciences & speciality opportunities
Portfolio Management ServiceStrategy AUM
Trailing 1Y return
Trailing Returns
APMI · annualised beyond 1Y · as of 01 May 2026
- 1M
- +6.82%
- 3M
- +7.55%
- 6M
- +16.46%
- 9M
- —
- 1Y
- +14.23%
- 2Y
- +17.32%
- 3Y
- +19.40%
- 4Y
- —
- 5Y
- —
- Since Inception
- +17.63%
- Strategy AUM
- ₹18 Cr
- Benchmark
- BSE 500 TRI
Performance vs Benchmark
Strategy vs BSE 500 TRI · trailing returns, % · alpha = excess
| Period | Strategy | Benchmark | Alpha |
|---|---|---|---|
| 1 Month | +6.82% | −0.17% | +6.99% |
| 3 Months | +7.55% | −2.34% | +9.89% |
| 6 Months | +16.46% | −5.39% | +21.85% |
| 1 Year | +14.23% | −0.07% | +14.30% |
| 2 Years | +17.32% | +4.14% | +13.18% |
| 3 Years | +19.40% | +13.46% | +5.94% |
| 4 Years | +0.00% | +0.00% | +0.00% |
| 5 Years | +0.00% | +0.00% | +0.00% |
| Since Inception | +17.63% | +13.91% | +3.72% |
Monthly Performance
Growth of ₹100 invested · month-on-month · 13 months
| Month | Strategy | Benchmark | Alpha |
|---|---|---|---|
| May-2026 | +6.82% | −0.17% | +6.99% |
| Apr-2026 | +12.26% | +10.38% | +1.88% |
| Mar-2026 | −10.31% | −11.37% | +1.06% |
| Feb-2026 | +8.77% | +0.45% | +8.32% |
| Jan-2026 | −0.64% | −3.34% | +2.70% |
| Dec-2025 | +0.14% | −0.24% | +0.38% |
| Nov-2025 | +0.21% | +0.96% | −0.75% |
| Oct-2025 | +0.58% | +4.27% | −3.69% |
| Sep-2025 | −5.46% | +1.24% | −6.70% |
| Aug-2025 | −10.19% | −1.75% | −8.44% |
| Jul-2025 | +8.48% | −2.71% | +11.19% |
| Jun-2025 | +5.65% | +3.68% | +1.97% |
| May-2025 | +9.90% | +3.54% | +6.36% |
Strategy Details
APMI fact sheet
- Inception
- 10 Feb 2023
- Age
- 3.3 Years
- Min. investment
- ₹50,00,000
- Turnover (1Y)
- 0.69×
- Turnover (1M)
- 0.00×
- Product
- Equity
as of 31 May 2026
Asset classes
Investment objective
Growth & Value
Fund Managers
1 manager
Name
Rajesh Pherwani
Experience
27.00 years
Fees & Investment
As disclosed to APMI
- Min. investment
- ₹50,00,000
- Fixed fees
- Not disclosed
- Variable fees
- Not disclosed
- Exit load
- Not disclosed
APMI does not publish a fee schedule for this strategy — confirm fees with the portfolio manager.
PMS Industry — SEBI
Latest monthly aggregate
- Total PMS AUM
- ₹44.11 Lakh Cr
- Total clients
- 2,23,279
- Discretionary
- ₹37.37 Lakh Cr
- Period
- july-2026
Industry AUM by asset class (top 5)
- Plain Debt Listed₹28.98 Lakh Cr
- Listed Equity₹7.60 Lakh Cr
- Plain Debt Unlisted₹5.00 Lakh Cr
- Mutual Funds₹1.93 Lakh Cr
- Others₹40,423 Cr
About
- Provider
- Valcreate Investment Managers LLP
- Strategy
- Valcreate Lifesciences & speciality opportunities
- Benchmark
- BSE 500 TRI
- Source
- APMI
Strategy performance, AUM, fees and fund-manager details are sourced from APMI (Association of Portfolio Managers in India); industry aggregates are from SEBI’s monthly PMS disclosures. Returns beyond one year are annualised; past performance is not indicative of future results, and a PMS strategy carries no capital guarantee. For information only, not investment advice.